[1]李秋慧,刘 荣,黎昌江,等.拉坦前列素治疗青光眼疗效及对患者房水转化生长因子-β2、一氧化氮及促红细胞生成素的影响[J].陕西医学杂志,2021,50(8):1003-1006.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.025]
　LI Qiuhui,LIU Rong,LI Changjiang,et al.Therapeutic effect of latanoprost in treatment of glaucoma and its effect on TGF-β2,NO and EPO in aqueous humor of patients[J].,2021,50(8):1003-1006.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.025]
点击复制

拉坦前列素治疗青光眼疗效及对患者房水转化生长因子-β2、一氧化氮及促红细胞生成素的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年8期
页码:
1003-1006
栏目:
药物与临床
出版日期:
2021-08-05

文章信息/Info

Title:
Therapeutic effect of latanoprost in treatment of glaucoma and its effect on TGF-β2,NO and EPO in aqueous humor of patients
作者:
李秋慧1; 刘 荣2; 黎昌江1; 王兆堰1; 黄梦运1
(1.琼海市人民医院眼科,海南 琼海 571400; 2.华中科技大学同济医学院附属同济医院,湖北 武汉430030)
Author(s):
LI Qiuhui; LIU Rong; LI Changjiang; WANG Zhaoyan; HUANG Mengyun
(Department of Ophthalmology,Qionghai People's Hospital,Qionghai 571400,China)
关键词:
青光眼;  拉坦前列素;  房水;  转化生长因子-β2;  一氧化氮;  促红细胞生长素
Keywords:
Glaucoma;  Latanoprost;  Aqueous humor;  Transforming growth factor-β2;  Nitric oxide;  Erythropoietin
分类号:
R 775.2
DOI:
DOI:10.3969/j.issn.1000-7377.2021.08.025
文献标志码:
A
摘要:
目的:探讨拉坦前列素治疗青光眼疗效及对患者房水转化生长因子-β2(TGF-β2)、一氧化氮(NO)、促红细胞生长素(EPO)的影响。方法:随机抽样法选取122例青光眼患者(单眼发病)。随机数字表法分为两组,各61例。对照组给予常规治疗,研究组在常规治疗同时应用拉坦前列素治疗。比较两组治疗效果及房水TGF-β2、NO、EPO水平,眼压、视野缺损、视网膜光敏感度、视力、视盘筛板血流量及血流速度情况。结果:治疗后研究组房水TGF-β2、NO、EPO水平均低于对照组(均P<0.05); 研究组眼压、视野缺损低于对照组,视网膜光敏感度、视力、血流量、血流速度均高于对照组(均P<0.05); 研究组总有效率为96.72%,高于对照组85.25%(P<0.05)。结论:青光眼治疗中应用拉坦前列素可促进眼压、视力、视盘筛板血流指标恢复,增强疗效,其内在机制与降低房水TGF-β2、NO、EPO水平有关。
Abstract:
Objective:To investigate the therapeutic effect of latanoprost in treatment of glaucoma and its effect on transforming growth factor-β2(TGF-β2),nitric oxide(NO)and erythropoietin(EPO)in aqueous humor of patients.Methods:122 glaucoma patients(monocular disease)were selected and divided into two groups,with 61 cases each.The control group was treated with conventional treatment,and the study group was treated with latanoprost on the basis of the control group.The therapeutic effect and the levels of TGF-β2,NO,and EPO in aqueous humor,intraocular pressure,visual field defect,retinal light sensitivity,visual acuity,optic disc lamina blood flow and blood flow velocity were compared between the two groups.Results:After treatment,the levels of TGF-β2,NO and EPO in the study group were lower than those in the control group,intraocular pressure and visual field defect in the study group were lower than those in the control group,and retinal light sensitivity,visual acuity,optic disc lamina blood flow and blood flow velocity were higher than those in the control group(all P<0.05).The total effective rate of the study group was 96.72%,which was higher than 85.25% of the control group(P<0.05).Conclusion:The application of latanoprost in the treatment of glaucoma can promote the recovery of intraocular pressure,visual acuity,and optic disc lamina blood flow indexes,and enhance the efficacy,and the internal mechanism is related to the reduction of T TGF-β2,NO,and EPO in aqueous humor.

参考文献/References:

[1] Peter W,Debby VD,Paul DDP.Intracranial pressure and glaucoma:Is there a new therapeutic perspective on the horizon?[J].Med Hypotheses,2018,118:98-102.
[2] Friedlander AH,Graves LL,Chang TI,et al.Prevalence of primary open-angle glaucoma among patients with obstructive sleep apnea[J].Oral Radi,2018,44(4):579-580.
[3] Wareham LK,Buys ES,Sappington RM.The nitric oxide-guanylate cyclase pathway and glaucoma[J].Nitric Oxide,2018,77:75-87.
[4] 任 虹,张 良.拉坦前列素联合小切口白内障超声乳化术对青光眼术后白内障患者的疗效及对并发症的影响分析[J].湖南师范大学学报:医学版,2020,17(2):82-85.
[5] 中华医学会.临床诊疗指南?眼科学分册[M].北京:人民卫生出版社,2012:48-50.
[6] 韩宝雁,米 强,贾冠美,等.拉坦前列素、噻吗洛尔和曲伏前列素治疗原发性开角型青光眼的疗效观察[J].河北医药,2020,42(9):1324-1327.
[7] Simonett JM,Huang D,Jia Y.Quantitative optical coherence tomography angiography of the peripapillary circulation in glaucoma[J].Ann Eye Sci,2018,2(8):8-11.
[8] 刘雪莲,吴桂花,张 燕.新生血管性青光眼患者房水和血浆中PLGF、IL-1β 和TGF-β2的测定及意义[J].河北医学,2019,25(9):1512-1515.
[9] 蒋鹏飞,黄学思,彭 俊,等.青光安有效组分对兔青光眼术后滤过道瘢痕组织中胶原纤维、成纤维细胞特异性蛋白-1、结缔组织生长因子及转化生长因子-β1表达的影响[J].中国中医药信息杂志,2019,26(5):59-63.
[10] 魏长征.鼠神经生长因子对青光眼术后患者BDNF、IGF-1、MCP-1、HCY、ET-1、NO水平的影响[J].中国药师,2019,22(3):504-507.
[11] 毛洪杰,车慧欣.Pentacam眼前节分析仪评价闭角型青光眼激光治疗前后眼前节参数变化研究[J].陕西医学杂志,2019,48(5):644-646.
[12] 陈 燕.活血化瘀利水汤治疗挫伤性前房积血继发性青光眼疗效及对患者视力状况影响的研究[J].陕西中医,2018,39(12):1738-1741.
[13] 许 多,阳建政,刘 莛,等.血管新生性青光眼患者房水中EPO、VEGF的表达研究[J].国际检验医学杂志,2020,41(1):78-81.
[14] 吴学志.平肝健脾汤治疗青光眼临床疗效及安全性研究[J].陕西中医,2019,40(1):91-93.
[15] 陈博宇,刘迎庆,安慧琴.复明片联合EX-Press引流器植入术治疗新生血管性青光眼疗效及对房水和血清中VEGF、EPO、IL-6表达的影响[J].现代中西医结合杂志,2018,27(30):3320-3323.
[16] 李 锐,袁慧敏,刘钊臣,等.复明片联合拉坦前列素治疗难治性青光眼的疗效观察[J].现代药物与临床,2020,35(1):127-132.
[17] 王 闰.尼莫地平辅助拉坦前列腺素治疗原发性开角型青光眼的临床研究[J].国际医药卫生导报,2019,25(20):3440-3443.
[18] 马迎春,伏文建.拉坦前列素治疗开角型青光眼的临床效果[J].世界最新医学信息文摘:连续型电子期刊,2019,19(47):151-152.
[19] 纪舒昱,钟 华,李 雷,等.拉坦前列素、曲伏前列素用于高眼压症、POAG患者治疗效果及安全性对照分析[J].昆明医科大学学报,2019,40(7):47-50.
[20] 邢 超,高常青,雷 苑,等.拉坦前列素和毛果芸香碱对DBA/2J小鼠房水动力学及眼压控制作用的研究[J].中国眼耳鼻喉科杂志,2019,19(4):232-235.
[21] 蔡羽恬,郭宁宁,郭 远,等.拉坦前列素对人表皮黑素细胞增殖与黑素合成的影响及机制探讨[J].中华皮肤科杂志,2019,52(6):408-413.
[22] 刘 爽,孔凡宏,施 歌.尼莫地平联合拉坦前列腺素治疗原发性开角型青光眼的疗效及对房水EPO ET-1 sCD44的影响[J].河北医学,2019,25(1):25-29.
[23] 姜 蕾,邓珍,吴一峰,等.拉坦前列腺素对开角型青光眼患者眼压角膜厚度眼血流及血浆内皮素-1的影响[J].中国药物与临床,2019,19(3):447-449.
[24] 张 敏,宋艳梅,冯 玮,等.拉坦前列素治疗开角型青光眼的疗效观察[J].国际眼科杂志,2018,18(6):1068-1071.
[25] 李继英,崔宏宇,张志宏,等.长期应用前列腺素类似物滴眼液对青光眼患者结膜菌群的影响[J].国际眼科杂志,2019,19(6):1052-1054.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金青年科学基金资助项目(81501552)
更新日期/Last Update: 2021-08-05